Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Thoracic Cancer|August 11, 2023
Healthcare utilization of lung cancer patients associated with exposure to fine particulate matter: A Korean cohort studyIn-Jae Oh, Cheol-Kyu Park, Kyoung-Bok Min, et al.
Tuberculosis and Respiratory Diseases|May 15, 2024
Immune Checkpoint Inhibitor Score Predicts Survival Benefit of Immunotherapy in Patients with Non-small Cell Lung CancerDa Hyun Kang, Chang-Min Choi, Cheol-Kyu Park, et al.
Thoracic Cancer|April 3, 2021
Efficacy and dose of afatinib in patients with non-small cell lung cancer after failure of prior gefitinib or erlotinib treatmentHayoung Choi, Jae-Kyeong Lee, Hyung-Joo Oh, et al.
Oncology|March 5, 2018
A Prospective Observational Study Evaluating the Correlation of c-MET Expression and EGFR Gene Mutation with Response to Erlotinib as Second-Line Treatment for Patients with Advanced/Metastatic Non-Small-Cell Lung CancerCheol-Kyu Park, In-Jae Oh, Yoo-Duk Choi, et al.
Thoracic Cancer|December 3, 2020
Phase II open-label multicenter study to assess the antitumor activity of afatinib in lung cancer patients with activating epidermal growth factor receptor mutation from circulating tumor DNA: Liquid-Lung-ACheol-Kyu Park, Sung-Yong Lee, Jae Cheol Lee, et al.
Human Immunology|November 3, 2009
Inverse association of peripheral blood CD4(+) invariant natural killer T cells with atopy in human asthmaYoung-Il Koh, Jae-Uoong Shim, Jeong-Ook Wi, et al.
Journal of Korean Medical Science|February 4, 2016
Predictors of Default from Treatment for Tuberculosis: a Single Center Case-Control Study in KoreaCheol-Kyu Park, Hong-Joon Shin, Yu-Il Kim, et al.
Cancer Research and Treatment|February 27, 2015
Peptide Nucleic Acid Clamping Versus Direct Sequencing for the Detection of EGFR Gene Mutation in Patients with Non-small Cell Lung CancerSeong-Hoon Yoon, Yoo-Duk Choi, In-Jae Oh, et al.
Cancers|March 11, 2023
A Propensity-Matched Retrospective Comparative Study with Historical Control to Determine the Real-World Effectiveness of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung CancerCheol-Kyu Park, Nakyung Jeon, Hwa-Kyung Park, et al.
Thoracic Cancer|June 21, 2025
Late-Onset Crizotinib-Associated Renal Cysts With Subsequent Regression Following Dose Reduction: A Case ReportJoon-Young Yoon, Won Gi Jeong, Yoo-Duk Choi, et al.
Pageof 9